Difference between revisions of "Osocimab (BAY-1213790)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "8 PubMed" to "8/ PubMed") |
||
| Line 4: | Line 4: | ||
==Preliminary data== | ==Preliminary data== | ||
===[[Venous thromboembolism]]=== | ===[[Venous thromboembolism]]=== | ||
| − | # '''FOXTROT:''' Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freitas MCS, Lassen MR, Metzig C, Raskob GE. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA. 2020 Jan 14;323(2):130-139. [https://jamanetwork.com/journals/jama/article-abstract/2758600 link to original article] [https://pubmed.ncbi.nlm.nih.gov/31935028 PubMed] | + | # '''FOXTROT:''' Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freitas MCS, Lassen MR, Metzig C, Raskob GE. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA. 2020 Jan 14;323(2):130-139. [https://jamanetwork.com/journals/jama/article-abstract/2758600 link to original article] [https://pubmed.ncbi.nlm.nih.gov/31935028/ PubMed] |
==Also known as== | ==Also known as== | ||
Revision as of 21:06, 4 May 2023
Mechanism of action
Anti-Factor XIa antibody
Preliminary data
Venous thromboembolism
- FOXTROT: Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freitas MCS, Lassen MR, Metzig C, Raskob GE. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA. 2020 Jan 14;323(2):130-139. link to original article PubMed
Also known as
- Code name: BAY 1213790